Despite this, the CDMO segment remained Akums' key growth driver, contributing Rs 804 crore, or 79 per cent of its total ...
Akums Drugs & Pharmaceuticals Ltd., India's Largest Contract Development and Manufacturing Organizations (CDMO), announced its financial results for the second quarter of FY26.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback